Revenue | ₹774.57Cr |
Net Profits | ₹113.20Cr |
Net Profit Margins | 14.61% |
Marksans Pharma Ltd’s revenue jumped 9.14% since last year same period to ₹774.57Cr in the Q3 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated 4.39% jump in its revenue since last 3-months.
Marksans Pharma Ltd’s net profit jumped 8.26% since last year same period to ₹113.20Cr in the Q3 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated 15.22% jump in its net profits since last 3-months.
Marksans Pharma Ltd’s net profit margin fell -0.8% since last year same period to 14.61% in the Q3 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated 10.37% jumped in its net profit margins since last 3-months.
The revenue for Marksans Pharma Ltd in the Q3 results 2025 was ₹774.57Cr.
The net profit for Marksans Pharma Ltd in the Q3 results 2025 was ₹113.20Cr.
The net profit margin for Marksans Pharma Ltd in the Q3 results 2025 was 14.61%.
The revenue for Marksans Pharma Ltd in the Q3 results 2024 was ₹709.70Cr.
The net profit for Marksans Pharma Ltd in the Q3 results 2024 was ₹104.56Cr.
The net profit margin for Marksans Pharma Ltd in the Q3 results 2024 was 14.73%.